Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
- Name
- Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
- Accession Number
- DBCAT005753
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Infigratinib An FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement. Erdafitinib A fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma. Pemigatinib A kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients. Futibatinib A kinase inhibitor used to treat intrahepatic cholangiocarcinoma in previously treated adults. - Drugs & Drug Targets